MCOLN2

Chr 1

mucolipin TRP cation channel 2

Also known as: TRP-ML2, TRPML2

The MCOLN2 protein functions as a nonselective cation channel that regulates membrane trafficking events and plays roles in immune processes including chemokine secretion and macrophage migration. Unlike MCOLN1 mutations which cause mucolipidosis IV, no specific human diseases have been definitively linked to MCOLN2 mutations despite the gene being expressed and functionally characterized. The gene shows minimal constraint against loss-of-function variants (very low pLI), suggesting haploinsufficiency may be well-tolerated.

Summary from RefSeq, UniProt
Research Assistant →
0
Active trials
3
Pubs (1 yr)
16
P/LP submissions
0%
P/LP missense
1.19
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryMCOLN2
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
16 unique Pathogenic / Likely Pathogenic· 73 VUS of 119 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.19LOEUF
pLI 0.000
Z-score 0.77
OE 0.84 (0.611.19)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
0.53Z-score
OE missense 0.91 (0.831.01)
278 obs / 303.9 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios
LoF OE0.84 (0.611.19)
00.351.4
Missense OE0.91 (0.831.01)
00.61.4
Synonymous OE1.05
01.21.6
LoF obs/exp: 24 / 28.4Missense obs/exp: 278 / 303.9Syn Z: -0.42
DN
0.6453th %ile
GOF
0.7030th %ile
LOF
0.3161th %ile

This gene has evidence for multiple mechanisms of pathogenicity (gain-of-function and dominant-negative). Both the Badonyi & Marsh prediction and the broader genomic evidence point to gain-of-function as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

GOFprediction above median
DNprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

119 submitted variants in ClinVar

Classification Summary

Pathogenic14
Likely Pathogenic2
VUS73
Likely Benign6
Benign6
14
Pathogenic
2
Likely Pathogenic
73
VUS
6
Likely Benign
6
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
14
0
14
Likely Pathogenic
0
0
2
0
2
VUS
0
72
1
0
73
Likely Benign
0
6
0
0
6
Benign
0
3
2
1
6
Total081191101

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

MCOLN2 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →